Arbutus Biopharma Corp (NASDAQ:ABUS)

4.04
Delayed Data
As of Jan 22
 +0.08 / +2.02%
Today’s Change
0.88
Today|||52-Week Range
9.02
+13.80%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$343.9M

Company Description

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.

Contact Information

Arbutus Biopharma Corp.
701 Veterans Circle
Warminster Pennsylvania 18974
P:(267) 469-0914
Investor Relations:

Employees

Shareholders

Mutual fund holders6.18%
Individual stakeholders23.66%
Other institutional20.86%

Top Executives

William H. CollierPresident, Chief Executive Officer & Director
David C. HastingsChief Financial & Accounting Officer
Michael J. SofiaChief Scientific Officer
Elizabeth HowardChief Compliance Officer, EVP & General Counsel
Michael J. McElhaughChief Business Officer